Injectable Drug Delivery Market Growth, COVID Impact, Trends Analysis Report 2021

Increasing prevalence and incidence of chronic diseases such as diabetes, hormonal disorder, and reproductive health issues are the factors that are driving the injectable drug delivery device market. Additionally, factors such as the need for patient-controlled drug release and increased risk of needle stick injuries are driving the injectable drug delivery market. The major advantage of injecting the drug is it enables the rapid transport of drug into the body through by-passing the first-pass metabolism and it facilitates the management of the drugs in comatose patients. It is widely used in different conditions that include cystic fibrosis, pain, hormonal imbalance, hepatitis C, autoimmune diseases, ribose-5-phosphate isomerase deficiency, and Wilson diseases. The two types of devices are used for injecting drugs that are conventional and self-injectable drug delivery devices. The drug delivery devices include pen injectors, needle-free injector, and auto-injectors. The auto-injector such as adrenaclick, Auvi-Q, Semjepi, and EpiPen. The needle-free injector includes gas-based needle-free injectors and spring-based needle-free injectors.

(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/injectable-drug-delivery-market

Moreover, the increase in technological advancement and innovation are driving the demand for injectable drug delivery market across the globe. Introduction of dual injectable drug delivery system has offered several advantageous functions and features that enhance safety, efficacy, compliance and usability and functions includes diagnostics and connectivity. The companies have introduced advanced devices to deliver drugs. For instance, in January 2019, Sandoz Inc., and Novartis announced the introduction of SYMJEPI injection for the treatment of allergic reactions type1 including allergen immunotherapy, drugs, diagnostic testing substance, and foods. The company launched medicine as a single dose. In 2018, AbbVie and Eisai have launched the HUMIRA an auto-injector formulation. It is the world human anti-TNF monoclonal antibody and it plays a vital role in the inflammatory response of autoimmune diseases, which includes rheumatoid arthritis.

A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/injectable-drug-delivery-market

Injectable drug delivery market is highly fragmented due to the presence of several market players that are signi ficantly operating across the globe. Some of the key players of the injectable drug delivery market include Cardinal Health, Inc., Gerresheimer AG, Schott AG, Becton, Dickinson and Co., Wilhelm Haselmeier GmbH & Co. KG, and Pfizer Inc. These market players provide a drug delivery system having industry-leading needle technologies, safety and shielding system, prefillable syringes and self-injection systems for hospitals, clinics, and homecare.

Current market trends report covered in the market report:

• Self-injectable drug delivery devices will exhibit considerable growth in the market.
• Insulin injections for treatment of diabetes hold a significant market share.
• North America will have a substantial share in the injectable drug delivery market due to significant market of prefilled syringes
• Homecare will have a considerable growth rate during the forecast period.

Global Injectable Drug Delivery Device Market – Segmentation

By Device Type
• Conventional Drug Delivery Devices
• Self-Injectable Drug Delivery Devices

By Application
• CVD
• Diabetes
• Oncology
• General Medication
• Vaccination
• Others (Autoimmune Disorders)

By End-User
• Hospitals
• Ambulatory Centers
• Clinics
• Homecare

Global Injectable Drug Delivery Device Market –Segment by region

North America
• United States
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

COMPANY PROFILES
• ALKERMES PLC
• ANTARES PHARMA
• BECTON DICKINSON AND COMPANY
• BIOPHARMA SOLUTIONS (BAXTER INTERNATIONAL INC.)
• ELI LILLY AND COMPANY
• GENENTECH INC.
• GERRESHEIMER AG

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/injectable-drug-delivery-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.